| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |